FDA Considering Charging Fees for Inclusion on Certified Export Lists
The FDA is considering charging fees for including firms on its export lists, which help give foreign governments and other parties information about whether a U.S. food export meets FDA standards or other U.S. regulations. Although the agency doesn’t currently charge firms to be included on export lists for human food, it said Nov. 8 it’s considering charging fees “to offset our costs.”
Sign up for a free preview to unlock the rest of this article
Export Compliance Daily combines U.S. export control news, foreign border import regulation and policy developments into a single daily information service that reliably informs its trade professional readers about important current issues affecting their operations.
Under the Federal Food, Drug, and Cosmetic Act, the FDA said it can collect up to $175 per certification for each company and its human food products that FDA “certifies through inclusion” on an export list. The agency is seeking public comments on this fee and whether exporters “have any specific suggestions about how FDA should approach the implementation of fees.” It also asked whether listed firms “experience any challenges” seeking a renewal and wants companies to “describe any challenges you have experienced with exporting human food products included on the export lists.”
Comments are due Jan. 7.